5-chloro-N4-(2-(ethylsulfinyl)-4-fluorophenyl)-N2-(2-methoxy-4-(4-methyl-1,4-diazepan-1-yl)phenyl)pyrimidine-2,4-diamine

ID: ALA4861523

PubChem CID: 164615858

Max Phase: Preclinical

Molecular Formula: C25H30ClFN6O2S

Molecular Weight: 533.07

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC[S+]([O-])c1cc(F)ccc1Nc1nc(Nc2ccc(N3CCCN(C)CC3)cc2OC)ncc1Cl

Standard InChI:  InChI=1S/C25H30ClFN6O2S/c1-4-36(34)23-14-17(27)6-8-21(23)29-24-19(26)16-28-25(31-24)30-20-9-7-18(15-22(20)35-3)33-11-5-10-32(2)12-13-33/h6-9,14-16H,4-5,10-13H2,1-3H3,(H2,28,29,30,31)

Standard InChI Key:  WHXOECBMCCQXEG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 36 39  0  0  0  0  0  0  0  0999 V2000
   34.4440   -4.5582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4428   -5.3856    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1577   -5.7985    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.8741   -5.3851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8712   -4.5547    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1559   -4.1455    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7295   -4.1459    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   35.1535   -3.3205    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   34.4377   -2.9101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4386   -2.0859    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7237   -1.6756    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0096   -2.0903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0147   -2.9195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.7301   -3.3260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1527   -1.6729    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   35.8675   -2.0848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1521   -0.8479    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.5892   -5.7965    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.7294   -7.0321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5905   -6.6215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8754   -7.0335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.8763   -7.8578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5920   -8.2700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3081   -7.8519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3037   -7.0291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0161   -6.6130    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.5818   -1.6718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.5944   -9.0950    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.8277   -9.4705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.6690  -10.2615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3374   -9.4573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5039  -10.2634    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.9544  -10.9236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1638  -10.9050    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.7906  -11.6408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.2933   -1.6809    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  6  8  1  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
 10 15  1  0
 15 16  1  0
 15 17  1  0
  4 18  1  0
 26 19  1  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 25 26  1  0
 16 27  1  0
 23 28  1  0
 28 29  1  0
 29 30  1  0
 28 31  1  0
 32 33  1  0
 33 34  1  0
 34 30  1  0
 31 32  1  0
 34 35  1  0
 12 36  1  0
M  CHG  2  15   1  17  -1
M  END

Alternative Forms

  1. Parent:

    ALA4861523

    ---

Associated Targets(Human)

NCI-H2228 (1030 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 533.07Molecular Weight (Monoisotopic): 532.1824AlogP: 5.03#Rotatable Bonds: 8
Polar Surface Area: 88.61Molecular Species: BASEHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.21CX Basic pKa: 8.85CX LogP: 4.05CX LogD: 2.59
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.39Np Likeness Score: -1.49

References

1. Wu F, Yao H, Li W, Zhang N, Fan Y, Chan ASC, Li X, An B..  (2021)  Synthesis and evaluation of novel 2,4-diaminopyrimidines bearing a sulfoxide moiety as anaplastic lymphoma kinase (ALK) inhibition agents.,  48  [PMID:34245852] [10.1016/j.bmcl.2021.128253]

Source